SRRK - Scholar Rock Holding Corp
45.29
-0.860 -1.899%
Share volume: 1,469,050
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$46.15
-0.86
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-14-2025 | 08-06-2025 | 11-14-2025 | 03-03-2026 | |
| Assets | |||||||||
| Total Assets | 267.285 M | 226.865 M | 179.133 M | 474.922 M | 407.553 M | 340.045 M | 411.718 M | 404.272 M | |
| Current Assets | 246.933 M | 199.137 M | 152.927 M | 451.165 M | 385.247 M | 319.126 M | 390.711 M | 385.147 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 146.453 M | 97.122 M | 62.674 M | 259.400 M | 226.449 M | 142.088 M | 82.860 M | 44.036 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 91.979 M | 93.372 M | 76.391 M | 177.878 M | 137.926 M | 152.925 M | 286.770 M | 323.527 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 4.038 M | 3.549 M | 3.156 M | 2.761 M | 2.639 M | 2.437 M | 2.116 M | 1.705 M | |
| Other Assets | 16.314 M | 24.179 M | 23.050 M | 20.996 M | 19.667 M | 18.482 M | 18.891 M | 17.420 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 267.285 M | 226.865 M | 179.133 M | 474.922 M | 407.553 M | 340.045 M | 411.718 M | 404.272 M | |
| Total liabilities | 84.512 M | 93.245 M | 99.937 M | 106.288 M | 95.220 M | 106.752 M | 166.723 M | 158.784 M | |
| Total current liabilities | 37.506 M | 32.987 M | 39.372 M | 46.936 M | 37.574 M | 50.435 M | 61.972 M | 55.419 M | |
| Accounts Payable | 2.868 M | 3.315 M | 4.071 M | 10.095 M | 4.437 M | 1.104 M | 6.765 M | 10.303 M | |
| Other liabilities | 2.412 M | 11.773 M | 10.466 M | 9.206 M | 7.905 M | 6.561 M | 5.140 M | 3.656 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 44.594 M | 48.485 M | 50.099 M | 50.146 M | 49.741 M | 49.756 M | 99.611 M | 99.709 M | |
| Other liabilities | 2.412 M | 11.773 M | 10.466 M | 9.206 M | 7.905 M | 6.561 M | 5.140 M | 3.656 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 182.773 M | 133.620 M | 79.196 M | 368.634 M | 312.333 M | 233.293 M | 244.995 M | 245.488 M | |
| Common stock | 916.097 M | 925.456 M | 935.329 M | 1.291 B | 1.310 B | 1.341 B | 1.455 B | 1.546 B | |
| Retained earnings | -733.274 M | -791.782 M | -856.261 M | -922.715 M | -997.438 M | -1.107 B | -1.210 B | -1.301 B |